Please use this identifier to cite or link to this item: https://hdl.handle.net/2440/135446
Citations
Scopus Web of Science® Altmetric
?
?
Type: Journal article
Title: Novel method to select meaningful outcomes for evaluation in clinical trials
Author: McLeod, C.
Norman, R.
Wood, J.
Mulrennan, S.
Morey, S.
Schultz, A.
Messer, M.
Spaapen, K.
Stoneham, M.
Wu, Y.
Smyth, A.
Blyth, C.
Webb, S.
Mascaro, S.
Woodberry, O.
Snelling, T.
Citation: BMJ Open Respiratory Research, 2021; 8(1):e000877-1-e000877-8
Publisher: BMJ
Issue Date: 2021
ISSN: 2052-4439
2052-4439
Statement of
Responsibility: 
Charlie McLeod, Richard Norman, Jamie Wood, Siobhain Mulrennan, Sue Morey, André Schultz, Mitch Messer, Kate Spaapen, Matthew Stoneham, Yue Wu, Alan Smyth, Christopher Blyth, Steve Webb, Steven Mascaro, Owen Woodberry, Tom Snelling
Abstract: Background: A standardised framework for selecting outcomes for evaluation in trials has been proposed by the Core Outcome Measures in Effectiveness Trials working group. However, this method does not specify how to ensure that the outcomes that are selected are causally related to the disease and the health intervention being studied. Causal network diagrams may help researchers identify outcomes that are both clinically meaningful and likely to be causally dependent on the intervention, and endpoints that are, in turn, causally dependent on those outcomes. We aimed to (1) develop a generalisable method for selecting outcomes and endpoints in trials and (2) apply this method to select outcomes for evaluation in a trial investigating treatment strategies for pulmonary exacerbations of cystic fibrosis (CF). Methods: We conducted a series of online surveys and workshops among people affected by CF. We used a modified Delphi approach to develop a consensus list of important outcomes. A workshop involving domain experts elicited how these outcomes were causally related to the underlying pathophysiological processes. Meaningful outcomes were prioritised based on the extent to which each outcome captured separate rather than common aspects of the underlying pathophysiological process. Results: The 10 prioritised outcomes were: breathing difficulty/pain, sputum production/clearance, fatigue, appetite, pain (not related to breathing), motivation/ demoralisation, fevers/night sweats, treatment burden, inability to meet personal goals and avoidance of gastrointestinal symptoms. Conclusions: This proposed method for selecting meaningful outcomes for evaluation in clinical trials may improve the value of research as a basis for clinical decisions.
Keywords: Lung
Humans
Cystic Fibrosis
Respiratory Therapy
Rights: © Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.
DOI: 10.1136/bmjresp-2021-000877
Grant ID: http://purl.org/au-research/grants/nhmrc/GNT1111657
http://purl.org/au-research/grants/nhmrc/1111596
http://purl.org/au-research/grants/nhmrc/1173163
Published version: http://dx.doi.org/10.1136/bmjresp-2021-000877
Appears in Collections:Medicine publications

Files in This Item:
File Description SizeFormat 
hdl_135446.pdfPublished version727.17 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.